Home » Newsletters » BioWorld

BioWorld

March 23, 1994

View Archived Issues

APHTON PRODUCT WELL TOLERATED

FDA TO REVIEW PLA FOR CENTOCOR'S CENTORX

SOMATOGEN DETAILS RHB1.1 STUDY

CORTEX EXTENDS WARRANT PERIODS

A MUTANT GENE FOR SCHIZOPHRENIA CHECKS OUT IN CASE-CONTROL STUDY

EPIGEN PRODUCT READY FOR TESTING IN APRIL

AGRIDYNE TECHNOLOGIES WINS TWO PATENTS, SBIR GRANT

EC COMMITTEE RECOMMENDS APPROVAL OF CEREDASE

BAXTER COLLABORATES CELL PROCESSING CENTERS TO BE DEVELOPED

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.